KCAT	Homo sapiens	121	bradykinin	*
KCAT	Homo sapiens	26	hippuryl-L-Arg	*
KCAT	Homo sapiens	52.4	hippuryl-L-Arg	*plasma-derived enzyme
KCAT	Homo sapiens	56.7	hippuryl-L-Arg	*recombinant enzyme
KCAT	Homo sapiens	2.67	hippuryl-Arg	*
KCAT	Bos taurus	2.74	hippuryl-Arg	*
KCAT	Homo sapiens	0.00004	hippuryl-arginine	*mutant S90D/S94V/S90D, activation of TAFI by plasmin
KCAT	Homo sapiens	0.00008	hippuryl-arginine	*mutant S90P, activation of TAFI by plasmin
KCAT	Homo sapiens	0.0002	hippuryl-arginine	*mutant P91S, activation of TAFI by plasmin
KCAT	Homo sapiens	0.0003	hippuryl-arginine	*mutant S94V, activation of TAFI by plasmin
KCAT	Homo sapiens	0.00039	hippuryl-arginine	*mutant R92K, activation of TAFI by plasmin
KCAT	Homo sapiens	0.00042	hippuryl-arginine	*wild-type, activation of TAFI by plasmin
KCAT	Homo sapiens	0.00043	hippuryl-arginine	*mutant A93V, activation of TAFI by plasmin
KCAT	Homo sapiens	15	Hippuryl-L-Lys	*
KCAT	Homo sapiens	40.7	Hippuryl-L-Lys	*plasma-derived enzyme
KCAT	Homo sapiens	45.6	Hippuryl-L-Lys	*recombinant enzyme
KCAT	Homo sapiens	0.205	p-anisylazoformyl-L-arginine	*mutant A93V, activation of TAFI by thrombin in the presence of thrombomodulin
KCAT	Homo sapiens	0.215	p-anisylazoformyl-L-arginine	*mutant R92K, activation of TAFI by thrombin in the presence of thrombomodulin
KCAT	Homo sapiens	0.315	p-anisylazoformyl-L-arginine	*wild-type, activation of TAFI by thrombin in the presence of thrombomodulin
KCAT	Homo sapiens	0.328	p-anisylazoformyl-L-arginine	*mutant S94V, activation of TAFI by thrombin in the presence of thrombomodulin
KCAT	Homo sapiens	0.377	p-anisylazoformyl-L-arginine	*mutant S90P, activation of TAFI by thrombin in the presence of thrombomodulin
KCAT	Homo sapiens	15.9	anisylazoformyl-Lys	*24&Acirc;&deg;C
KCAT	Homo sapiens	26.8	anisylazoformyl-Lys	*24&Acirc;&deg;C
KCAT	Homo sapiens	27	anisylazoformyl-Lys	*24&Acirc;&deg;C
KCAT	Homo sapiens	27.4	anisylazoformyl-Lys	*24&Acirc;&deg;C
KCAT	Homo sapiens	29.5	anisylazoformyl-Lys	*24&Acirc;&deg;C
KCAT	Homo sapiens	29	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*
KCAT	Homo sapiens	248	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*recombinant enzyme
KCAT	Homo sapiens	293	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*plasma-derived enzyme
KCAT	Homo sapiens	169	Hippuryl-L-argininic acid	*
KCAT	Homo sapiens	748	Arg6-Leu5-enkephalin	*
KCAT	Homo sapiens	647	Arg6-Met5-enkephalin	*
KCAT	Homo sapiens	282	Lys6-Leu5-enkephalin	*
KCAT	Homo sapiens	290	Lys6-Met5-enkephalin	*
KCAT	Homo sapiens	36	N-[3-(2-Furylacryloyl)]-L-Ala-L-Arg	*
KCAT	Homo sapiens	64	N-benzoyl-Gly-L-Arg	*in 50 mM HEPES (pH 8.0) at 25&Acirc;&deg;C
KCAT	Homo sapiens	2.3	biotinyl-(epsilon-aminocaproic acid)-(epsilon-aminocaproic acid)-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Arg-OH	*room temperature
KCAT	Homo sapiens	59	N-benzoyl-2'-cyano-L-Phe-L-Arg	*in 50 mM HEPES (pH 8.0) at 25&Acirc;&deg;C
KM	Homo sapiens	-999	more	*binding kinetics of recombinant wild-type and chimeric mutant isozymes to fibrinogen and plasminogen, overview
KM	Homo sapiens	0.000005	hippuryl-arginine	*mutant S90D/S94V/S90D, activation of TAFI by plasmin; wild-type, activation of TAFI by plasmin
KM	Homo sapiens	0.000006	hippuryl-arginine	*mutant R92K, activation of TAFI by plasmin; mutant S94V, activation of TAFI by plasmin
KM	Homo sapiens	0.000007	hippuryl-arginine	*mutant P91S, activation of TAFI by plasmin
KM	Homo sapiens	0.000009	hippuryl-arginine	*mutant S90P, activation of TAFI by plasmin
KM	Homo sapiens	0.00001	hippuryl-arginine	*mutant A93V, activation of TAFI by plasmin
KM	Homo sapiens	0.000162	p-anisylazoformyl-L-arginine	*mutant S90P, activation of TAFI by thrombin in the presence of thrombomodulin
KM	Homo sapiens	0.000169	p-anisylazoformyl-L-arginine	*mutant A93V, activation of TAFI by thrombin in the presence of thrombomodulin
KM	Homo sapiens	0.000178	p-anisylazoformyl-L-arginine	*wild-type, activation of TAFI by thrombin in the presence of thrombomodulin
KM	Homo sapiens	0.000229	p-anisylazoformyl-L-arginine	*mutant R92K, activation of TAFI by thrombin in the presence of thrombomodulin
KM	Homo sapiens	0.000232	p-anisylazoformyl-L-arginine	*mutant S94V, activation of TAFI by thrombin in the presence of thrombomodulin
KM	Homo sapiens	0.012	biotinyl-(epsilon-aminocaproic acid)-(epsilon-aminocaproic acid)-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Arg-OH	*room temperature
KM	Homo sapiens	0.02	N-benzoyl-2'-cyano-L-Phe-L-Arg	*in 50 mM HEPES (pH 8.0) at 25&deg;C
KM	Homo sapiens	0.84	N-benzoyl-Gly-L-Arg	*in 50 mM HEPES (pH 8.0) at 25&deg;C
KM	Homo sapiens	0.979	anisylazoformyl-Lys	*24&deg;C
KM	Homo sapiens	1.089	anisylazoformyl-Lys	*24&deg;C
KM	Homo sapiens	1.11	anisylazoformyl-Lys	*24&deg;C
KM	Homo sapiens	1.12	hippuryl-L-Arg	*
KM	Homo sapiens	1.26	anisylazoformyl-Lys	*24&deg;C
KM	Homo sapiens	1.45	Hippuryl-L-Lys	*
KM	Homo sapiens	2.38	hippuryl-Arg	*Vmax: 44.86 micromol/l/min
KM	Homo sapiens	3.41	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*recombinant enzyme
KM	Bos taurus	3.44	hippuryl-Arg	*Vmax: 46.05 micromol/l/min
KM	Homo sapiens	4.71	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*plasma-derived enzyme
KM	Homo sapiens	10	bradykinin	*
KM	Homo sapiens	63	Arg6-Leu5-enkephalin	*
KM	Homo sapiens	110	Lys6-Leu5-enkephalin	*
KM	Homo sapiens	140	Arg6-Met5-enkephalin	*
KM	Homo sapiens	180	hippuryl-L-Arg	*
KM	Homo sapiens	210	N-[3-(2-Furylacryloyl)]-L-Ala-L-Arg	*
KM	Homo sapiens	220	Lys6-Met5-enkephalin	*
KM	Homo sapiens	240	Hippuryl-L-argininic acid	*
KM	Homo sapiens	270	Hippuryl-L-Lys	*
KM	Homo sapiens	280	N-[3-(2-Furylacryloyl)]-L-Ala-L-Lys	*
KM	Homo sapiens	766	Hippuryl-L-Lys	*plasma-derived enzyme
KM	Homo sapiens	783	hippuryl-L-Arg	*recombinant enzyme
KM	Homo sapiens	817	hippuryl-L-Arg	*plasma-derived enzyme
KM	Homo sapiens	933	Hippuryl-L-Lys	*recombinant enzyme
MW	Homo sapiens	12000	*	*x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE
MW	Homo sapiens	12000	*	*x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE
MW	Homo sapiens	25000	*	*x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE
MW	Homo sapiens	25000	*	*x * 25000 + x * 12000, derived by cleavage at Arg330, inactive form, SDS-PAGE
MW	Homo sapiens	35000	*	*x * 35000, active enzyme
MW	Homo sapiens	35000	*	*x * 35000, active enzyme
MW	Homo sapiens	35000	*	*x * 35000, active enzyme
MW	Homo sapiens	35000	*	*x * 35000, processed mature glycosylated enzyme, SDS-PAGE
MW	Homo sapiens	35000	*	*Western blot
MW	Homo sapiens	46000	*	*x * 46000, enzymes rTAFI and pTAFI, deglycosylated enzymes, slight differences in MW might be due to differences in glycosylation, SDS-PAGE
MW	Homo sapiens	53000	*	*x * 53000, SDS-PAGE, gel filtration after treatment with guanidine-HCL
MW	Homo sapiens	60000	*	*x * 60000, SDS-PAGE
MW	Homo sapiens	60000	*	*x * 60000, SDS-PAGE
MW	Homo sapiens	60000	*	*x * 60000
MW	Homo sapiens	435000	*	*gel permeation chromatography
SA	Homo sapiens	-999	*	*
SA	Homo sapiens	-999	*	*
SA	Canis lupus familiaris	-999	*	*electroluminescence assay. The high sensitivity of the assay allows the determination of the activatable levels of TAFI in human and other animal plasma in presence of epsilon-aminocaproic acid, an active-site inhibitor that stabilizes TAFIa
SA	Chlorocebus aethiops	-999	*	*electroluminescence assay. The high sensitivity of the assay allows the determination of the activatable levels of TAFI in human and other animal plasma in presence of epsilon-aminocaproic acid, an active-site inhibitor that stabilizes TAFIa
SA	Homo sapiens	-999	*	*electroluminescence assay. The high sensitivity of the assay allows the determination of the activatable levels of TAFI in human and other animal plasma in presence of epsilon-aminocaproic acid, an active-site inhibitor that stabilizes TAFIa
SA	Macaca mulatta	-999	*	*electroluminescence assay. The high sensitivity of the assay allows the determination of the activatable levels of TAFI in human and other animal plasma in presence of epsilon-aminocaproic acid, an active-site inhibitor that stabilizes TAFIa
SA	Rattus norvegicus	-999	*	*electroluminescence assay. The high sensitivity of the assay allows the determination of the activatable levels of TAFI in human and other animal plasma in presence of epsilon-aminocaproic acid, an active-site inhibitor that stabilizes TAFIa
SA	Homo sapiens	-999	*	*binding capacity of recombinant wild-type and chimeric mutant isozymes to fibrinogen and plasminogen, overview
SA	Homo sapiens	-999	*	*
SA	Rattus norvegicus	-999	*	*in vivo arteriovenous shunt thrombosis model, ex vivo clot lysis assay
SA	Homo sapiens	-999	*	*coupled assay methods, overview
SA	Homo sapiens	-999	*	*assay development and optimization, overview
SA	Homo sapiens	-999	*	*plasminogen and fibrinogen binding activity of the enzyme
SA	Homo sapiens	-999	*	*develpoment of a fast kinetic assay for plasma enzyme quantification, coupled assay with pyruvate kinase/lactate dehydrogenase in microtiter plates, reaction scheme overview
SA	Homo sapiens	-999	*	*TAFI activity changes during gestation
SA	Homo sapiens	-999	*	*enzyme plasma concentration of healthy male persons, correlation of enzyme plasma concentration to cardiovascular diseases, overview
SA	Canis lupus familiaris	-999	*	*hemodynamics in untreated hearts of dogs and hearts treated with enzyme inhibitor MERGETPA and/or plasminogen activator, overview
SA	Homo sapiens	0.017	*	*substrate hippuryl-L-Arg
SA	Homo sapiens	8	*	*substrate hippuryl-L-Lys
SA	Homo sapiens	11.4	*	*substrate hippuryl-L-Arg
SA	Homo sapiens	2000	*	*
